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Reactive Oxygen Species and Their Detoxification
in Healing Skin Wounds
Ulrich auf dem Keller1, Angelika Ku¨min1, Susanne Braun1 and Sabine Werner1
Injury to the skin initiates a cascade of events, which finally lead to at least partial reconstruction of the
wounded tissue. The wound-healing process has been well described at the histological level, but the
underlying molecular mechanisms are still poorly defined. To gain insight into these mechanisms we searched
for genes, which are regulated by skin injury. Interestingly, some of the genes that we identified encode
cytoprotective proteins, in particular enzymes, which detoxify reactive oxygen species (ROS). Since ROS are
produced in high amounts at the wound site as a defense against invading bacteria, the expression of these
genes is most likely important for the protection of cells against these toxic molecules. In this review, we
summarize the results on the expression of cytoprotective genes in wounded skin, and we discuss their
possible roles in the wound-healing process.
Journal of Investigative Dermatology Symposium Proceedings (2006) 11, 106–111. doi:10.1038/sj.jidsymp.5650001
INTRODUCTION
Cutaneous injury initiates a series of events, including
inflammation, new tissue formation, and matrix remodeling,
which finally lead to at least partial reconstruction of the
wounded tissue (Martin, 1997). These processes are well
described at the histological level, but the underlying
molecular mechanisms are still poorly understood. Our
previous studies suggested that genes, which are regulated
by skin injury, are of functional importance for the repair
process. Therefore, we performed differential display reverse
transcriptase PCR, subtractive hybridization, and microarray
analysis to identify genes, which are up- or downregulated
within 24 hours after the generation of full-thickness exci-
sional skin wounds in mice (Munz et al., 1999; Thorey et al.,
2001; Kaesler et al., 2004; Beer et al., 2005). The identified
genes encode, for example, various growth factors, cytokines,
extracellular matrix molecules, cytoskeletal proteins, tran-
scription factors, and enzymes. Interestingly, among the latter
are several enzymes known to be involved in ROS
detoxification. In addition, one of the injury-regulated genes
encodes the transcription factor NF-E2-related factor 2 (Nrf2),
a known regulator of ROS-detoxifying enzymes. In this
review, we summarize the current knowledge on the
expression of these genes in wounded skin and their potential
function in the repair process.
ROS IN WOUND HEALING
During the inflammatory phase of wound-healing neutrophils
and macrophages invade the wound. Neutrophils arrive first
within a few minutes and are abundant at the wound site
within 1–3 hours after wounding. Subsequently, lymphocytes
and monocytes also invade the wound tissue and the latter
differentiate into activated macrophages (Singer and Clark,
1999). Neutrophils and macrophages produce large amounts
of superoxide radical anions, a phenomenon, which is often
described as the ‘‘respiratory burst’’. Furthermore, other cells
such as fibroblasts can be stimulated by pro-inflammatory
cytokines to produce ROS (Meier et al., 1989). The
generation of these reactive molecules is part of the innate
immune system and helps to rapidly clean the wound from
invading bacteria (Clark, 1996). The driving enzyme for the
conversion of molecular oxygen to superoxide radical anions
is nicotinamide adenine dinucleotide phosphate (reduced
form) oxidase, which resides within both phagosomal
membranes and the plasma membrane of phagocytic cells
(Wientjes and Segal, 1995). Superoxide radical anions can be
dismutated by superoxide dismutases (SODs) to mole-
cular oxygen and hydrogen peroxide. The latter is readily
diffusible through biological membranes and may be con-
verted to the highly reactive hydroxyl radical (Figure 1)
(Fridovich, 1978).
Besides their beneficial role in microbial killing ROS can
have a series of negative effects. For example, at low levels,
hydrogen peroxide and other ROS inhibit migration and
proliferation of various cell types, including keratinocytes
(O’Toole et al., 1996). At high levels ROS can lead to severe
tissue damage and even neoplastic transformation (Cerutti
and Trump, 1991). The proliferating and migrating cells in the
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wound tissue are exposed to large amounts of ROS during the
respiratory burst and thus have to develop strategies to
protect themselves against these harmful insults.
ANTIOXIDANT DEFENSE SYSTEMS
To protect themselves from oxidative stress, cells have
developed several systems to detoxify ROS. In general, there
are two major strategies, which convey partial resistance
against oxidative stress to most cell types: non-enzymatic and
enzymatic. The first comprises small antioxidant molecules
like vitamin E, vitamin C, b-carotene, glutathione (GSH), co-
enzmye Q, and bilirubin, which function to quench ROS.
The second consists of ROS-detoxifying enzymes, including
among others SODs, the seleno-enzyme GSH peroxidase
(SeGPx), and catalase (Fridovich, 1978; Michiels et al., 1994;
Shindo et al., 1994). SODs catalyze the dismutation of
superoxide anions to molecular oxygen and hydrogen
peroxide. The latter can be further detoxified by catalase or
by GSH peroxidases (GPx), which include, for example the
SeGPx and members of the peroxiredoxin (Prx) family. The
action of GPx involves oxidation of GSH to GSH disulfide
(Figure 1). Normally the ratio between GSH and GSH
disulfide is 10–100 in the cell. Disruption of this ratio, for
example by enhanced formation of GSH disulfide, leads to an
imbalanced redox state and oxidative stress. Therefore, the
cell tries to maintain this ratio by enhanced activity of GSH
reductase and/or removal of GSH disulfide (Schafer and
Buettner, 2001). Furthermore, g-glutamylcysteinyl synthase,
the rate-limiting enzyme in GSH biosynthesis, is activated
upon reduction of cellular GSH levels (Soltaninassab et al.,
2000).
Owing to the high levels of ROS present in wounded skin,
the expression of ROS-detoxifying enzymes in healing skin
wounds appears to be of particular importance, and we have
therefore determined the expression and function of some of
these genes in the wound-repair process.
SUPEROXIDE DISMUTASES IN WOUND REPAIR
The superoxide radical anion is the major ROS generated
during the respiratory burst of inflammatory cells. It can be
detoxified by three types of SOD, the cytosolic Cu/Zn-
dependent enzyme (SOD1), the mitochondrial Mn-depen-
dent variant (SOD2), or an extracellular variant (SOD3). To
gain insight into a potential role of SODs in cutaneous wound
repair, we determined the expression of Cu/Zn-SOD and
Mn-SOD in full-thickness skin wounds in mice. As shown by
RNase protection assay (Figure 2), mRNAs encoding both
enzymes were expressed at a low level in normal mouse back
skin. After wounding, their expression increased with a
similar kinetics, and highest levels of SOD mRNAs were
found at the early stage of wound repair, when the oxidative
burst occurs. The upregulation of Cu/Zn-SOD was more
prolonged compared to that of Mn-SOD, and elevated mRNA
levels were still found at day 7 after wounding (Steiling et al.,
1999). In situ hybridization of sections from 5-day wounds
revealed the presence of particularly high levels of Cu/Zn-
SOD mRNA in the hyperproliferating basal cells of the
wound epidermis as well as in a few cells of the dermis and
granulation tissue. mRNA encoding Mn-SOD was found in
basal and suprabasal cells of the hyperproliferative wound
epidermis. In early wounds, Mn-SOD mRNA was also seen in
cells of the clot, which most likely represent neutrophils.
Using immunohistochemistry, the sites of expression of the
two types of SOD in the wound tissue were confirmed at the
protein level (Steiling et al., 1999). Thus, inflammatory cells
and in particular keratinocytes of the wound epidermis
appear to have a high capacity to detoxify superoxide radical
anions.
CATALASE, SEGPx, AND PHOSPHOLIPID
HYDROPEROXIDE GPx IN WOUND REPAIR
Although hydrogen peroxide, the product of the reaction
catalyzed by SODs, is not a radical, it can give rise to the
highly reactive hydroxyl radical in the presence of transition
metals (Fenton reaction). Therefore, it is essential to rapidly
detoxify hydrogen peroxide. This can be achieved by catalase
as well as by different types of peroxidases. Of particular
importance is the SeGPx I, which is also able to reduce a
wide variety of organic peroxides (Wendel, 1981). As shown
in Figure 2, expression of SeGPx increased after wounding
with maximal mRNA levels being found between days 3 and
5 after injury. At 14 days after the insult, when the wound
was completely healed, expression of this enzyme had almost
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Figure 1. Generation and detoxification of ROS. Superoxide anions are
generated at high levels by the inflammatory cell-derived nicotinamide
adenine dinucleotide phosphate (reduced form) oxidase. These radicals are
dismutated by SODs, resulting in the generation of hydrogen peroxide and
molecular oxygen. Hydrogen peroxide is a substrate of catalase and of various
peroxidases, including SeGPx and PrxVI. The latter use GSH as a substrate,
which is concomitantly oxidized to GSH disulfide. De novo formation of the
tripeptide GSH is achieved in two enzymatic reactions, with the formation of
g-glutamylcysteine as the rate-limiting step. If hydrogen peroxide is not
rapidly detoxified by catalase and peroxidases, it can give rise to the highly
toxic hydroxyl radical through Fenton reaction.
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declined to the basal level. By contrast, expression of catalase
as well as of phospholipid hydroperoxide GPx (PhGPx),
which uses phospholipid hydroperoxides as a substrate, was
not altered by skin injury (Steiling et al., 1999). Similar to the
expression pattern of SODs, the hyperproliferative wound
epithelium and the hair follicles at the wound edge were also
the predominant sites of expression of catalase, SeGPx, and
phospholipid hydroperoxide glutathione peroxidase as
shown by in situ hybridization of 5-day wounds. mRNAs
encoding catalase and SeGPx were found in all layers of the
wound epidermis, whereas phospholipid hydroperoxide
glutathione peroxidase mRNA levels were particularly high
in the basal and lower suprabasal layers. In addition,
transcripts encoding all of these enzymes were found in the
dermis and granulation tissue, although at lower abundance
compared to the epidermis. The co-expression of SODs and
peroxide-detoxifying enzymes strongly suggests that hydro-
gen peroxide produced by SODs is rapidly detoxified,
thereby avoiding the generation of the aggressive hydroxyl
radical.
PEROXIREDOXIN VI IN WOUND REPAIR
In addition to the classical peroxidases, recent studies
revealed that members of the Prx family can also detoxify
hydrogen peroxide as well as a wide variety of organic
peroxides. Whereas, PrxI–V contain two reactive cysteines
and utilize thioredoxin and/or GSH as a substrate (Hofmann
et al., 2002; Wood et al., 2003), PrxVI or 1-Cys-Prx has a
single redox-active cysteine and it uses GSH to catalyze the
reduction of hydrogen peroxide and various organic per-
oxides. Additionally, PrxVI has been reported to have
phospholipase A2 activity (Manevich and Fisher, 2005).
Previous studies have shown that overexpression of PrxVI
prevents from ROS-induced cytotoxicity, whereas knockout
of the gene in mice caused enhanced sensitivity to oxidative
injury (Manevich et al., 2002; Wang et al., 2003, 2004).
Thus, PrxVI is likely to have an important cytoprotective
function.
A role of PrxVI in wound healing was first suggested by the
identification of PrxVI as the product of a wound-regulated
gene in our laboratory (Munz et al., 1997). By RNase
protection assay we found highest levels of the PrxVI mRNA
at day 1 after injury. Elevated levels were still seen until day 7
after wounding, but expression declined to the basal levels
seen in unwounded skin when the wound was fully healed
(day 14 after wounding) (Figure 2). The peak of PrxVI protein
expression was observed at day 5 after wounding. By
contrast, expression of PrxI was unaltered after injury (data
not shown). Using in situ hybridization we found highest
levels of PrxVI mRNA in keratinocytes of the hyperprolifera-
tive wound epidermis (Munz et al., 1997) (Figure 3). In vitro
studies demonstrated that PrxVI expression is strongly
enhanced in keratinocytes by keratinocyte growth factor
(Frank et al., 1997). Since the latter is also highly upregulated
in wounded skin (Werner et al., 1992), our findings suggest
that this growth factor may also be responsible for the
upregulation of PrxVI in wounded skin. Independent of the
inducers, the expression pattern of PrxVI in healing skin
wounds suggests that this enzyme protects keratinocytes
against oxidative stress and acts together with SeGPx in the
detoxification of the SOD product hydrogen peroxide.
Furthermore, the potent activity of PrxVI towards phospho-
lipid hydroperoxides further indicates that this enzyme also
reduces peroxidation of membrane lipids. Functional studies
to determine the role of PrxVI in the healing response are
currently in progress.
HEME OXYGENASES IN WOUND REPAIR
Besides the ROS-detoxifying enzymes described above,
additional antioxidant proteins are likely to be key players
in wound repair. One of them is heme oxygenase (HO), the
rate-limiting enzyme in the degradation of heme into carbon
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Figure 2. Upregulation of ROS-detoxifying enzymes in healing skin wounds.
Full-thickness excisional skin wounds were generated on the back of Balb/c
mice as described by Wankell et al. (2001). RNA was isolated from
non-wounded skin (back skin) as well as from wound tissue obtained
at different time points after injury as indicated on top of the figure. Twenty
micrograms of total cellular RNA was analyzed by RNase protection assay
for the presence of mRNAs encoding Cu/Zn-SOD, Mn-SOD, SeGPx,
PrxVI, HO-1, and Nrf2. One microgram aliquots of the same batch of
RNAs were analyzed on a 1% agarose gel and stained with ethidium
bromide (shown below the RNase protection assays).
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monoxide, iron, and biliverdin that is subsequently reduced
to bilirubin, a potent antioxidant (Tenhunen et al., 1968;
Baranano et al., 2002). Three different HO isoforms have
been described, including the inducible isoform HO-1, the
mostly constitutive isoform HO-2, and HO-3, with low
enzymatic activity (Elbirt and Bonkovsky, 1999). Expression
of HO-1 is induced by its substrate heme, but also following
exposure to various stressful stimuli, including UV irradia-
tion, hydrogen peroxide, nitric oxide, phorbol esters, heavy
metals, and organic chemicals (Applegate et al., 1991). Most
interestingly, many of the known HO-1 inducers stimulate
the production of ROS or lead to depletion of GSH,
suggesting an involvement of HO-1 activity in the cellular
protection against oxidative stress. Therefore, we determined
the expression of HO-1 and HO-2 during the healing process
of full-thickness excisional wounds in mice (Hanselmann
et al., 2001). We found a remarkable induction of HO-1
mRNA and protein expression one day after skin injury
(Figure 2 and data not shown). After completion of wound
healing, HO-1 expression declined to basal levels (Figure 2).
By contrast, expression of HO-2 was not significantly
modulated by skin injury (data not shown). In situ hybridiza-
tion and immunohistochemistry revealed high HO-1 expres-
sion in inflammatory cells of the granulation tissue and in
keratinocytes of the hyperproliferative epithelium (Figure 3
and Hanselmann et al., 2001). Using in vitro studies with
cultured keratinocytes we identified hydrogen peroxide and
the ROS-producer menadione as strong inducers of HO-1
expression in keratinocytes, suggesting that ROS are also
responsible for the upregulation in vivo. By contrast,
proinflammatory cytokines and growth factors had no effect
(Hanselmann et al., 2001). Taken together, our findings
suggest a novel role of HO-1 in wound-healing where it
might be involved in the protection of cells from the toxic
effects of ROS through formation of the antioxidant bilirubin.
In addition, a recent study suggests an additional role of HO
in wound-healing through its function in heme degradation
(Wagener et al., 2003). These investigators found a strong
accumulation of heme at the edges of skin wounds, resulting
in heme-induced influx of leukocytes. Therefore, the en-
hanced expression of HO at the wound site is likely to be
required to attenuate the inflammatory response.
NRF2 IN WOUND REPAIR
The expression of various ROS-detoxifying enzymes and
other cytoprotective proteins in healing skin wounds raises
the question about their regulation. Interestingly, many of
these genes are under the control of the Nrf2 transcription
factor. The latter is a member of the ‘‘cap’n’ collar’’ family of
transcription factors, which, among others, also includes the
closely related proteins Nrf1 and Nrf3 (Motohashi and
Yamamoto, 2004). Together with their heteromeric interac-
tion partners, the small Maf proteins, they bind to cis-acting
elements in the promoters of target genes, called antioxidant
response elements. At least the binding of Nrf1 and Nrf2
activates the expression of these genes, which encode, for
example GSH S-transferase Ya subunit, g-glutamylcysteinyl
synthase, HO-1 and PrxI (Nguyen et al., 2003). In addition, a
recent study suggests that PrxVI is also under the control of
Nrf2 (Lee et al., 2003).
In the absence of specific activators, Nrf2 is localized in
the cytosol via binding to the actin-binding protein Keap1,
which also mediates its degradation via the ubiquitin-
proteasome pathway. Upon addition of electrophilic sub-
stances, which couple to Keap1 through Michael addition,
and possibly through oxidation of Keap1 via ROS, Nrf2
becomes liberated and shuttles to the nucleus, where it
activates its target genes. In addition, phosphorylation of Nrf2
by different kinases can also result in liberation from Keap1
(Itoh et al., 2004; Nguyen et al., 2004). In a recent study, we
demonstrated a strong increase in the expression of Nrf2 as
well as of its target genes HO-1 and GSH S-transferase Ya in
healing skin wounds (Figure 2 and Braun et al. (2002)).
Highest expression levels of Nrf2 were seen in cells of the
granulation tissue, which most likely represent macrophages,
as well as in the hyperproliferative wound epithelium
(Figure 3) (Braun et al., 2002). The expression of Nrf2 in
wound keratinocytes correlates with the expression of many
of its target genes (see above), suggesting that the enhanced
levels of Nrf2 seen at the site of injury result in upregulation
of ROS-detoxifying enzymes and other cytoprotective pro-
teins. To determine the importance of Nrf2 for the wound-
healing process, we performed wound-healing studies in Nrf2
knockout mice. The expression of several key players
involved in wound repair was strongly reduced in early
wounds of Nrf2-deficient mice, and prolonged inflammation
was seen in the late phase of repair. Surprisingly, however,
these differences in gene expression and inflammation were
not reflected by wound-healing abnormalities. This may be
explained by the observed upregulation of Nrf3, which was
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Figure 3. Genes encoding cytoprotective proteins are predominantly
expressed in the hyperproliferative wound epidermis. Paraformaldehyde-
fixed frozen sections from 5-day full-thickness excisional skin wounds were
analyzed by in situ hybridization for the presence and localization of mRNAs
encoding HO-1, PrxVI, SeGPx, and Nrf2. Note the strong expression of all of
these genes in the hyperproliferative wound epidermis. D: dermis; Es: eschar;
G: granulation tissue; HE, hyperproliferative wound epidermis. Original
magnification  100.
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co-expressed with Nrf2 in the hyperproliferative wound
epidermis (Braun et al., 2002). Therefore, this transcription
factor may compensate for the lack of Nrf2 during wound
healing. Studies using genetically modified animals, which
lack both Nrf2 and Nrf3 and possibly also Nrf1 in the wound
will help to identify the role of Nrf transcription factors in the
healing response.
CONCLUSION
The results described above suggest that a thorough regula-
tion of the levels of ROS in wounded skin is required for
efficient repair. On the one hand, production of ROS by
inflammatory cells and other cell types in the wound is
required for the defense against invading bacteria (Figure 4),
and at physiological levels ROS are also important regulators
of various intracellular signaling pathways (Forman et al.,
2002). On the other hand, enhanced levels of ROS are
detrimental and can lead to severe cell damage. This effect
may be further enhanced by ROS-mediated inhibition of the
activity of various ROS-scavenging enzymes (Pigeolet et al.,
1990; Vessey and Lee, 1993). Therefore, the observed
upregulation of various genes encoding antioxidative proteins
in keratinocytes and other cell types of the healing skin
wound might be a strategy for efficient ROS detoxification in
the harsh wound environment (Figure 4). The increased
mRNA expression of several ROS-scavenging enzymes that
we observed after skin injury seems to be in contrast to
findings of other investigators (Shukla et al., 1997), who
found reduced SOD and GPx activities in wound tissue
between days 2 and 7 after cutaneous injury in rats. The
discrepancy between these results and our mRNA data may
be explained by inhibition of the enzymatic activities of these
enzymes at the wound site by the high levels of ROS (Pigeolet
et al., 1990; Vessey and Lee, 1993).
Given the obvious importance of ROS detoxification in
healing skin wounds, it seems likely that reduced levels of
ROS-detoxifying enzymes result in healing impairments, a
hypothesis, which is supported by the observation of reduced
activities of SOD, catalase, and GPx in wounds of aged rats
compared to young rats (Anamika and Shukla, 2000); by the
beneficial effect of antioxidants on wound healing in
ischemic rat skin (Senel et al., 1997) and by the restoration
of the delayed wound healing seen in diabetic mice by
adenoviral delivery of Mn-SOD to the wound site (Luo et al.,
2004). Furthermore, a large number of observations suggest a
role of enhanced ROS levels in the pathogenesis and
pathophysiology of chronic leg ulcers (Wlaschek and
Scharffetter-Kochanek, 2005). Consistent with this hypo-
thesis, preliminary studies from our laboratory indeed suggest
that the lack of PrxVI in mice is associated with wound-
healing abnormalities (A.K. and S.W., unpublished data).
Wound-healing studies in other genetically modified animals
with altered expression of ROS-detoxifying enzymes will
allow to determine the function of individual components of
the ROS defense system for the wound-healing process. An
even more elegant approach will be the use of inducible
systems, which allow the induction of a transgene or the
deletion of an endogenous gene in a time- and tissue-specific
manner (Lewandoski, 2001). This strategy will circumvent the
problem of systemic defects and will also prevent abnormal
organ development. The latter is important, since a wound-
repair phenotype might be secondary to a defect already
present in non-wounded skin or to systemic abnormalities,
which influence the repair process. Thus, by induction of a
transgene or deletion of an endogenous gene prior to injury,
the role of this particular gene in the healing response can be
analyzed in the absence of secondary abnormalities. This
type of study will most likely resolve a number of the
issues that we brought up in this review as well as unravel
exciting novel functions of ROS-detoxifying enzymes in
tissue repair.
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